The U.S. Food and Drug Administration (FDA) has cleared Aidoc's expanded AI triage system BriefCase, with 11 new indications, according to the firm.
Powered by Aidoc's Clinical AI Reasoning Engine (CARE) Foundation Model, the system for abdomen CT triage enables facilities to identify time-sensitive critical cases earlier, the company said, adding that it brings a total of 14 indications together into a single workflow. With emergency department (ED) imaging typically read first-in, first-out, BriefCase is designed to relieve ED overcrowding and imaging backlogs.
The 11 newly cleared indications achieved a mean sensitivity of 97% (up to 98.5%) and a mean specificity of 98% (up to 99.7%), the company noted.
